The proteomics data show how tumor-associated MUC1 can influence the tumor microenvironment by mechanisms such as (1) upregulating or downregulating multiple targets (2) which lead to amino acid depletion, maintenance of a hypoxic environment, and ROS production, (3) thus leading to reduced anti-tumor activity of the lymphocytes. This evidence concerns the gene MUC1 and neoplasm.